GSK's (GSK) "Equal Weight" Rating Reiterated at Barclays

Barclays reissued their equal weight rating on shares of GSK (LON:GSK - Free Report) in a research note published on Tuesday, MarketBeat Ratings reports. The firm currently has a GBX 1,725 ($21.67) price objective on the stock.

Several other equities research analysts also recently issued reports on GSK. JPMorgan Chase & Co. increased their price target on GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an underweight rating in a report on Thursday, May 2nd. Berenberg Bank increased their price target on GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the stock a buy rating in a report on Wednesday, February 14th. Shore Capital restated a buy rating on shares of GSK in a report on Wednesday, May 1st. Finally, Deutsche Bank Aktiengesellschaft restated a buy rating and issued a GBX 1,950 ($24.50) price target on shares of GSK in a report on Wednesday, April 17th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of Hold and an average target price of GBX 1,675.63 ($21.05).

GSK Trading Up 1.7 %

LON GSK traded up GBX 29.04 ($0.36) on Tuesday, reaching GBX 1,762.54 ($22.14). The company had a trading volume of 15,331,153 shares, compared to its average volume of 6,932,162. The stock's 50 day moving average is GBX 1,666.29 and its 200-day moving average is GBX 1,562.88. The stock has a market cap of £72.09 billion, a price-to-earnings ratio of 1,468.79, a PEG ratio of 1.12 and a beta of 0.27. The company has a quick ratio of 0.73, a current ratio of 0.88 and a debt-to-equity ratio of 140.82. GSK has a 52 week low of GBX 1,302.60 ($16.36) and a 52 week high of GBX 1,767.50 ($22.20).

GSK Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th will be given a dividend of GBX 15 ($0.19) per share. The ex-dividend date of this dividend is Thursday, May 16th. This represents a dividend yield of 0.9%. GSK's dividend payout ratio is currently 5,333.33%.

Insider Transactions at GSK

In other news, insider Urs Rohner acquired 434 shares of GSK stock in a transaction dated Wednesday, March 20th. The stock was bought at an average cost of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). In related news, insider Urs Rohner purchased 434 shares of GSK stock in a transaction that occurred on Wednesday, March 20th. The stock was purchased at an average cost of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). Also, insider Emma Walmsley sold 139,792 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.83), for a total value of £2,317,751.36 ($2,911,747.94). 1.77% of the stock is owned by insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.